Mortality among individuals co-infected with HIV and hepatitis C virus (HCV) is relatively high. We evaluated the association between psychoactive substance use and both HCV and non-HCV mortality in HIV/HCV co-infected patients in France, using Fine and Gray's competing-risk model adjusted for socio-demographic, clinical predictors and confounding factors, while accounting for competing causes of death. Over a 5-year median follow-up period, 77 deaths occurred among 1028 patients. Regular/daily cannabis use, elevated coffee intake, and not currently smoking were independently associated with reduced HCV-mortality (adjusted sub-hazard ratio [95% CI] 0.28 [0.10-0.83], 0.38 [0.15-0.95], and 0.28 [0.10-0.79], respectively). Obesity and severe thinness were associated with increased HCV-mortality (2.44 [1.00-5.93] and 7.25 [2.22-23.6] versus normal weight, respectively). Regular binge drinking was associated with increased non-HCV-mortality (2.19 [1.10-4.37]). Further research is needed to understand the causal mechanisms involved. People living with HIV/HCV co-infection should be referred for tobacco, alcohol and weight control interventions and potential benefits of cannabis-based therapies investigated.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10461-019-02585-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
"Tethered to this ball and chain": Women's perspectives on bodily agency within opioid treatment programs.
Int J Drug Policy
December 2024
Consortium on Substance Use and Addiction, Pennsylvania State University, USA; Department of Human Development and Family Studies, Pennsylvania State University, USA.
Article Synopsis
- Methadone Maintenance Treatment (MMT) is effective in reducing risks related to opioid use disorder (OUD), but less than 10% of those affected in the U.S. receive it, particularly among women involved in the criminal justice system.
- A study involving interviews with women in Pennsylvania and substance use disorder professionals highlighted that women feel their bodily agency is compromised by strict OTP policies, which can harm their treatment experience and retention.
- The research calls for MMT programs to adopt a more patient-centered and trauma-informed approach, emphasizing the importance of empowering women in their treatment decisions to enhance effectiveness.
Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States.
Addiction
February 2025
Massachusetts Department of Public Health, Bureau of Substance Addiction Services and Grayken Center for Addiction, Section of General Internal Medicine, Boston Medical Center and Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
Background And Aims: During the COVID-19 pandemic, there was a surge in opioid overdose deaths (OODs) in Massachusetts, USA, particularly among Black and Hispanic/Latinx populations. Despite the increasing racial and ethnic disparities in OODs, there was no compensatory increase in naloxone distributed to these groups. We aimed to evaluate two community-based naloxone expansion strategies, with the objective of identifying approaches that could mitigate mortality and racial and ethnic disparities in OODs.
View Article and Find Full Text PDFNo impact of HIV coinfection on the mortality in patients with hepatitis C virus infection after sustained virological response.
Clin Infect Dis
September 2024
Cinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.
Background: In patients with hepatitis C virus (HCV) chronic infection and advanced liver disease, the impact of human immunodeficiency virus (HIV) coinfection on the clinical outcome after sustained virological response (SVR) has not been sufficiently clarified. The aim of this study was to compare the mortality after SVR of patients bearing HCV chronic infection and advanced liver fibrosis, with and without HIV-coinfection after a prolonged follow-up.
Methods: This was a prospective multicenter cohort study including individuals with HIV/HCV-coinfection and patients with HCV-monoinfection from Spain, fulfilling: 1) Liver stiffness (LS) ≥9.
Chronic liver disease is becoming a leading cause of illness and mortality in patients living with human immunodeficiency virus (HIV; PLWH) undergoing suppressive anti-retroviral therapy. Its primary etiology is coinfection with hepatitis B and C virus (HBV and HCV, respectively). Chronic liver inflammation and fibrosis can potentially lead to the development of hepatocellular carcinoma (HCC).
View Article and Find Full Text PDFHepatitis co-infection in paediatric HIV: progressing treatment and prevention.
Curr Opin HIV AIDS
November 2024
Hepatology Unit, Meyer Children's Hospital IRCCS.
Purpose Of Review: To analyse the main evidence and recommendations for the management of hepatitis co-infection in children living with HIV.
Recent Findings: We analysed available data pertaining to the natural history of liver disease and treatment of co-infected children.
Summary: Viral hepatitis co-infection in people living with HIV (PLHIV) is a global problem owing to the shared routes of transmission, particularly in areas of high endemicity for the three viruses.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!